Innovating Works

DRFZ

4D-SkINFLAM: Spatio-temporal integration of skin inflammation DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN tramitó un HORIZON EUROPE: ERC-2022-ADG To ‘feel comfortable in one’s own skin’ is an idiom referring to one’s confidence in interacting with others. However, when the skin is infl...
2023-09-12 - 2028-09-30 | Financiado
MEM-CLONK: Imprinting and clonality of human NK cell memory DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN tramitó un HORIZON EUROPE: ERC-2021-ADG The pool of innate immune effector cells is wired to rapidly respond to pathogens, whereas only few specificities within the naïve adaptive...
2022-07-07 - 2027-08-31 | Financiado
3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado
RTCure: Rheuma Tolerance for Cure DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN participó en un H2020: H2020-JTI-IMI2-2016-09-two-stage In line with IMI2 goals for improved therapies and precision medicine, the aim of this proposal is to prevent and treat RA or its progressio...
2017-08-25 - 2023-08-31 | Financiado
PREG-LAB: Distinctive characterization of regulatory plasma cells and pro inflammatory B cells in immunity th... DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN participó en un H2020: ERC-2014-CoG B cells can act both as negative regulators and as drivers of immunity through the production of cytokines. Through secretion of interleukin...
2015-12-14 - 2021-12-31 | Financiado
NKG2D-IMMUNO: The role of NKG2D in CD4 T cell function and autoimmunity DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN tramitó un FP7: More than 5 million people in Europe live with inflammatory bowel disease (IBD) or rheumatoid arthritis (RA). Both diseases are characterize...
Financiado
IMMEMO: Protective and pathogenic immunological memory and its organisation by stroma cells DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN tramitó un FP7: "Immunological memory provides immunity against recurrent pathogens, but also can induce and regulate immunopathology. In chronic immune-med...
Financiado
PRECISESADS: Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN participó en un FP7: We concur to the IMI on Reclassification of SLE, connective tissue diseases and RA call by presenting a proposal aimed at using the power of...
Financiado
BTCURE: BeTheCuRE DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN participó en un FP7: BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal model...
Financiado
PHARMACHILD: Long term PHARMacovigilance for Adverse effects in Childhood arthritis focussing on Immune modulator... DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN participó en un FP7: Until the age of biotechnology, treatment options for children and adolescents with severe arthritis, inflammatory bowel diseases and other...
Financiado
OSTEOIMMUNE: OSTEOIMMUNE Unraveling the Interactions between the Immune System and Bone DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN participó en un FP7: Inflammatory rheumatic diseases affect millions of European citizens causing chronic pain, disability and premature death. Curative treatmen...
Financiado
EUTRAIN: EUropean TRanslational training for Autoimmunity Immune manipulation Network DEUTSCHES RHEUMA FORSCHUNGSZENTRUMBERLIN participó en un FP7: Immune-mediated inflammatory diseases (IMID) are important health challenges in Europe and beyond, afflicting an estimated 5-8% of the total...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.